Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors

Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors

A series of dietary flavonoid acacetin 7-<i>O</i>-methyl ether derivatives were computationally designed aiming to improve the selectivity and potency profiles against monoamine oxidase (MAO) B. The designed compounds were evaluated for their potential to inhibit human MAO-A and -B. Comp...

Full description

Bibliographic Details
Main Authors:	Vedanjali Gogineni, Manal A. Nael, Narayan D. Chaurasiya, Khaled M. Elokely, Christopher R. McCurdy, John M. Rimoldi, Stephen J. Cutler, Babu L. Tekwani, Francisco León
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Biomedicines
Subjects:	flavonoids Parkinson’s Disease monoamine oxidases A and B acacetin docking
Online Access:	https://www.mdpi.com/2227-9059/9/10/1304

Similar Items

Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from <i>Turnera diffusa</i> (Damiana)
by: Narayan D. Chaurasiya, et al.
Published: (2019-02-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

Selective Interactions of <i>O</i>-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
by: Narayan D. Chaurasiya, et al.
Published: (2020-11-01)

Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ in vivo
by: Gabriela A. Perez-Barron, et al.
Published: (2020-01-01)

Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
by: Mehmet Abdullah Alagöz, et al.
Published: (2022-06-01)

Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
by: Muhammed Çeçen, et al.
Published: (2020-11-01)

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
by: Payyalot Koyiparambath Vishal, et al.
Published: (2021-06-01)

Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein–Inhibitor Complexes in Relevance to Developing Parkinson’s Therapeutics
by: Natarajan Arul Murugan, et al.
Published: (2020-10-01)

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
by: Marcin Cieślak, et al.
Published: (2024-04-01)

Potent Xanthine Oxidase Inhibitory Activity of Constituents of <i>Agastache rugosa</i> (Fisch. and C.A.Mey.) Kuntze
by: Heung Joo Yuk, et al.
Published: (2023-01-01)

The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics
by: Chantal A. Pileggi, et al.
Published: (2023-01-01)

Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B
by: Narayan D. Chaurasiya, et al.
Published: (2021-04-01)

Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors
by: Begüm Nurpelin Sağlık, et al.
Published: (2020-09-01)

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
by: Priyanka Dhiman, et al.
Published: (2019-01-01)

Fármacos multifuncionais: monoamina oxidase e α-sinucleína como alvos terapêuticos na doença de Parkinson Multifunctional drugs: monoamine oxidase and α-synuclein as targets for the treatment of Parkinson's disease
by: Cristian Follmer, et al.
Published: (2013-01-01)

Fármacos multifuncionais: monoamina oxidase e α-sinucleína como alvos terapêuticos na doença de Parkinson
by: Cristian Follmer, et al.
Published: (2013-01-01)

Sex Difference in Cardioprotection against Acute Myocardial Infarction in MAO-B Knockout Mice In Vivo
by: Jacqueline Heger, et al.
Published: (2023-03-01)

Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
by: Nisha Abdul Rehuman, et al.
Published: (2022-09-01)

Molecular docking approach of monoamine oxidase B inhibitors for identifying new potential drugs: Insights into drug-protein interaction discovery
by: Salimeh Raeisi
Published: (2013-11-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Design, synthesis and in-vitro anti-depressant activity evaluation of some 2-styrylbenzimidazole derivatives
by: Manisha Sahariah, et al.
Published: (2024-02-01)

The Antidepressant-like Effect of Flavonoids from <i>Trigonella Foenum-Graecum</i> Seeds in Chronic Restraint Stress Mice via Modulation of Monoamine Regulatory Pathways
by: Jiancheng Wang, et al.
Published: (2019-03-01)

Identification of New <i>N</i>-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
by: Ashraf K. El-Damasy, et al.
Published: (2023-01-01)

Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
by: Junichi Kitanaka, et al.
Published: (2006-01-01)

Binding mechanism of naringenin with monoamine oxidase – B enzyme: QM/MM and molecular dynamics perspective
by: Hunday Govindasamy, et al.
Published: (2021-04-01)

Green Oxidation of Amines by a Novel Cold-Adapted Monoamine Oxidase MAO P3 from Psychrophilic Fungi <i>Pseudogymnoascus</i> sp. P3
by: Iga Jodłowska, et al.
Published: (2021-10-01)

New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
by: Liliana Pacureanu, et al.
Published: (2023-05-01)

Design, synthesis and evaluation of semi- and thiosemicarbazides containing a methylxanthine moiety with in vitro neuroprotective and MAO-B inhibitory activities
by: Javor Mitkov, et al.
Published: (2022-12-01)

A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023
by: Reshma Susan Ipe, et al.
Published: (2023-09-01)

A Systematic Study of the Mechanism of Acacetin Against Sepsis Based on Network Pharmacology and Experimental Validation
by: Yuanshuo Ouyang, et al.
Published: (2021-08-01)

Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson’s Disease
by: Xuebao Wang, et al.
Published: (2017-06-01)

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education
by: Richard G. Wenzel, et al.
Published: (2010-06-01)

Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
by: Andy Wai Kan Yeung, et al.
Published: (2019-05-01)

Serotonin syndrome induced by anti-parkinsonism drugs：a case report
by: WU Dongdong, LI Shuhua, SU Wen, LIU Yinghong, CHEN Haibo, CHEN Di
Published: (2023-06-01)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
by: Zhenxin Zhang, et al.
Published: (2018-12-01)

Integrated Metabolite and Transcriptome Profiling-Mediated Gene Mining of <i>Sida cordifolia</i> Reveals Medicinally Important Genes
by: Deepthi Padmanabhan, et al.
Published: (2022-10-01)

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches
by: Linfeng Zheng, et al.
Published: (2022-10-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)